Comparison 24. Mizoribine: 150 mg (once/day) versus 50 mg (3 times/day).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
24.1 Complete or partial remission	1	37	Risk Ratio (M‐H, Random, 95% CI)	0.76 [0.51, 1.13]
24.2 Complete remission	1	37	Risk Ratio (M‐H, Random, 95% CI)	1.35 [0.66, 2.78]
24.3 Partial remission	1	37	Risk Ratio (M‐H, Random, 95% CI)	0.24 [0.06, 0.97]
24.4 Relapse after complete or partial remission	1	27	Risk Ratio (M‐H, Random, 95% CI)	0.42 [0.05, 3.51]
24.5 Adverse events	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
24.5.1 Adverse events	1	37	Risk Ratio (M‐H, Random, 95% CI)	Not estimable
24.5.2 Infection	1	37	Risk Ratio (M‐H, Random, 95% CI)	Not estimable
24.5.3 Malignancy	1	37	Risk Ratio (M‐H, Random, 95% CI)	4.75 [0.24, 92.65]